Acetylsalicylic acid Active Not Recruiting Phase 4 Trials for Coronary Heart Disease (CHD) / Percutaneous Transluminal Coronary Angioplasty Treatment

Active Not RecruitingTreatment4 IdentifierTitleDrugs
NCT02939872Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events
NCT02044250Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- EXtended Antiplatelet Monotherapy (HOST-EXAM)